Manipal Health Enterprises IPO listing
Analysis based on 8 articles · First reported Aug 05, 2026 · Last updated Aug 05, 2026
The successful listing and strong debut reflect positive investor sentiment towards India's healthcare sector and the company's growth prospects. The funds raised will strengthen Manipal Health Enterprises' balance sheet by reducing debt and supporting expansion, potentially boosting its stock performance and the broader hospital industry.
Manipal Health Enterprises, a leading Indian multispecialty hospital chain, made a strong stock market debut on August 5, 2026, listing at an 11% premium to its IPO price of ₹590 on both the BSE and NSE. The stock ended the day 13% higher, giving the company a market valuation of approximately ₹87,696 crore. The IPO, which raised ₹9,275 crore, was subscribed 4.92 times, with strong demand from institutional investors. The company plans to use the proceeds to repay debt of its subsidiary Manipal Health Enterprises and acquire a minority stake in Sahyadri Hospitals, among other purposes.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard